James DArecca - Insider Trading & Ownership

Location
C/O Haemonetics Corporation, 125 Summer Street, Boston, MA
Summary
The estimated net worth of James DArecca is at least $5M dollars as of August 6, 2025. James DArecca is the Chief Financial Officer of TherapeuticsMD, Inc. and owns shares of TherapeuticsMD, Inc. (TXMD) stock worth about $2.46M. James DArecca is the EVP, Chief Financial Officer of HAEMONETICS CORP and owns shares of HAEMONETICS CORP (HAE) stock worth about $1.96M. James DArecca is the Director of Prestige Consumer Healthcare Inc. and owns shares of Prestige Consumer Healthcare Inc. (PBH) stock worth about $574K.
Signature
/s/ James C. D'Arecca by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated July 5, 2023 on file with the Commission
All Insider Reports
All Insider Reports

Ownership of James DArecca

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TXMD TherapeuticsMD, Inc. Chief Financial Officer $2.46M Aug 10, 2021
HAE HAEMONETICS CORP EVP, Chief Financial Officer $1.96M May 30, 2025
PBH Prestige Consumer Healthcare Inc. Director $574K Aug 5, 2025

Insider Transactions Reported by James DArecca:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.